Peptide storage is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-07-03. Numbers and descriptions here follow the published literature rather than marketing material.
Material supplied for laboratory use is normally a lyophilised white to off-white powder that dissolves readily in water and in isotonic saline. Lyophilised cakes are hygroscopic and should be equilibrated to room temperature before opening to limit condensation on the solid. Solutions are typically prepared at milligram-per-millilitre concentrations and divided into single-use aliquots, because repeated freeze–thaw cycles degrade short peptides. Aqueous solutions are far less stable than the dry powder, and identity is usually verified by mass spectrometry alongside purity estimation from reversed-phase high-performance liquid chromatography.
Epitalon is a synthetic linear tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and the calculated mass is approximately 390.35 g/mol. The compound is made by solid-phase peptide synthesis rather than extracted from tissue, although early work described it as a short fragment of a peptide fraction obtained from bovine pineal extract. In the research literature the spelling epitalon and the variant epithalone both appear, while AEDG is the standard code used in peptide nomenclature.
Identity is normally established by reversed-phase high-performance liquid chromatography combined with mass spectrometry, a pairing that separates components and confirms molecular mass at once. Purity is quoted as a percentage from the chromatogram, and figures above ninety-five percent are a frequent commercial specification. Amino acid analysis or sequencing supplies further confirmation when required. Because many short peptides behave similarly under chromatography, retention time alone does not establish sequence; the mass measurement is what separates one tetrapeptide from another, and certificates should report both.
Short peptides such as AEDG are normally supplied as a freeze-dried solid and are kept dry, cold, and shielded from light. Holding at minus twenty degrees Celsius is common for the long term, while a refrigerator suffices for brief periods before use. The material takes up moisture to some degree, so containers should stay sealed and be allowed to reach room temperature before opening, which limits condensation on the contents. Repeated warming and cooling of a single container is discouraged because it admits water and can lower the amount of intact peptide.
| Property | Value | Notes |
|---|---|---|
| Amino acid sequence | Ala-Glu-Asp-Gly | Linear tetrapeptide, also written AEDG |
| Molecular mass | About 390.35 g/mol | Value calculated from the sequence |
| Appearance | White to off-white powder | Lyophilised material forms a loose cake |
| Solubility | Freely soluble in water | Also dissolves in isotonic saline |
| Storage | -20 °C, desiccated | Aliquot solutions to avoid freeze–thaw cycling |
The peptide is a synthetic analogue of epithalamin, a preparation extracted from bovine pineal glands. Investigators sought a short, chemically defined molecule that would reproduce some of the endocrine and gerontological observations attributed to the glandular extract. Proposed mechanisms centre on induction of telomerase activity, an effect reported in cultured human somatic cells in the early 2000s, together with influences on melatonin secretion and neuroendocrine regulation. Those mechanisms remain incompletely characterised, and the reported telomerase response has not been consistently reproduced by independent groups working in comparable systems.
Published work on this compound consists mainly of in vitro experiments, animal studies, and small clinical investigations, a substantial share of which appeared in Russian-language journals. Sample sizes are generally small, control conditions differ between studies, and several endpoints rely on markers whose clinical meaning is itself debated. Reviews of the longevity field treat the peptide as an early example of telomerase-directed research rather than an established intervention. Regulatory treatment varies by country: some jurisdictions place it under prescription controls, others treat it as a laboratory material, and importation may be restricted regardless of local status.
Epitalon is a synthetic tetrapeptide whose sequence is alanine–glutamate–aspartate–glycine, commonly abbreviated AEDG. It was developed in Russia during the 1980s and 1990s by investigators associated with the St. Petersburg Institute of Bioregulation and Gerontology, who studied short peptides as regulators of gene expression and tissue function. The alternative spelling epithalon appears interchangeably in the literature, and the two names refer to the same molecule. Outside Russia it is encountered chiefly as a research chemical rather than a licensed medicine, and it holds no approval from the United States Food and Drug Administration or the European Medicines Agency.
Identity testing for epitalon relies on reversed-phase high-performance liquid chromatography for purity and mass spectrometry for mass confirmation. Because the sequence contains no tryptophan or tyrosine, ultraviolet detection at 280 nanometres is insensitive, so chromatographic methods usually monitor absorbance near 214 nanometres, where the peptide backbone absorbs. Electrospray ionisation or matrix-assisted laser desorption/ionisation then checks the intact mass against the expected value near 390 daltons. Peptide mapping or amino acid analysis after acid hydrolysis can supplement these measurements, although such confirmatory work is seldom reported on commercial certificates of analysis.
Stability of the tetrapeptide follows ordinary peptide chemistry rather than any unusual structural feature. The aspartate-glycine pair is prone to aspartimide formation under mildly basic or neutral conditions, and deamidation can follow, altering both mass and chromatographic retention. Dry lyophilised powder kept at or below minus twenty degrees Celsius is the usual handling recommendation, with repeated freeze-thaw cycles avoided. Once dissolved in neutral aqueous buffer, degradation proceeds over days to weeks depending on pH and temperature, while acidic conditions generally slow the aspartimide route. A formal stability-indicating study has not been published in the indexed literature.
The compound is generally described as a synthetic analogue of a fragment isolated from a pineal gland extract. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology introduced it during the 1980s and 1990s while studying short peptides from animal tissue. The original extract, called epithalamin, is a heterogeneous mixture, whereas epitalon is a single defined sequence. That distinction matters because findings reported for the extract are not automatically findings about the pure tetrapeptide, and claims about broader biological effects remain a separate question from the chemical identity described here.
Residue composition is the property that most cleanly separates verified material from mislabelled samples. Alanine, glutamate, aspartate and glycine appear in that order from the N-terminus, and the two acidic residues sit in the middle of the chain. Because the peptide is short, it can be produced by solid-phase synthesis and characterised by mass spectrometry without ambiguity. Any reported sample whose measured mass departs substantially from 390 daltons is a different compound or a degraded mixture rather than epitalon.
Epitalon is a synthetic tetrapeptide whose four residues are alanine, glutamate, aspartate and glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9 and its monoisotopic mass is near 390.35 daltons. The peptide carries two acidic side chains, so it is neutral to negatively charged in most aqueous buffers. Published reference summaries usually list it under both spellings, epitalon and epithalon, and treat the two names as the same material.
Freeze-dried epitalon is normally kept at minus twenty degrees Celsius in a sealed, desiccated container, protected from light. Short excursions at ambient temperature during shipping are generally tolerated, but repeated warming and cooling cycles encourage moisture uptake, which shortens shelf life. Once dissolved, the peptide is far less stable than the solid: aqueous solutions are subject to hydrolysis and to deamidation at the aspartate and glutamate residues. Working solutions are therefore held refrigerated and used within days, and repeated freezing and thawing of the same vial is best avoided.
Identity and purity are checked by reversed-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, where the peptide bond absorbs. Mass spectrometry confirms the expected mass and reveals whether truncation products or adducts are present. Acid hydrolysis followed by amino acid analysis gives the residue ratio, which should approximate one alanine, one glutamate, one aspartate and one glycine. Counter-ions such as acetate or trifluoroacetate remain in the dried product and lower net peptide content, so a stated purity figure on a label does not by itself describe how much peptide a vial holds.
Regulatory treatment differs by country. No formulation of epitalon holds a marketing authorisation as a medicine in the United States or the European Union, where material sold for laboratory use is handled as a research chemical and is not intended for human consumption. In Russia, several short peptide preparations from the same institute's peptide series are registered medicinal products, and epitalon appears in that national context. Elsewhere it is frequently offered as a cosmetic ingredient, a category with lighter requirements. Advertising claims about longevity or disease prevention are restricted in most jurisdictions, which limits how sellers describe the compound.
=== Retinoblastoma === More recent studies have identified ITGA1 as a potential therapeutic target in retinoblastoma (Rb). ITGA1 promotes Rb progression by activating the FAK/STAT3 signaling pathway. Restoration of STAT3 partially reverses the effects of ITGA1 inhibition, supporting the role of this pathway in ITGA1-mediated tumor growth. Genetic knockdown or pharmacological inhibition of ITGA1 suppresses retinoblastoma cell proliferation, migration, colony formation, and growth in vivo. Inhibition of the α1β1 integrin receptor using genetic approaches or the α1β1 inhibitor obtustatin reduces tumor progression, suggesting that ITGA1-targeted therapies may represent a potential strategy for treating high-risk retinobloastoma. However, further research and testing are needed to confirm the safety and efficacy of ITGA1 inhibition before it is used as a clinical treatment.
==== Distribution ==== The volume of distribution of propranolol is about 4 L/kg or 320 L. The plasma protein binding of propranolol is approximately 90%, with a range of 85 to 96% in different studies. Propranolol is a highly lipophilic drug achieving high concentrations in the brain. The brain-to-blood ratio of propranolol in humans ranges from 15:1 to 33:1, whereas the ratio for the peripherally selective beta blocker atenolol has been found to be 0.2:1.
Tenkaonian Goren Nashi (テンカオ星人ゴレン・ナシ, Tenkao Seijin Goren Nashi) and Tenkaonian Yam Tomukun (テンカオ星人ヤム・トムクン, Tenkao Seijin Yamu Tomukun): Namunan's partners of the same species who are killed by Chou San. Goren Nashi is voiced by Seiji Fujita (藤田 清二, Fujita Seiji), who also portrays his human form; Yam Tomukun is portrayed by Minoru Nanaeda (七枝 実, Nanaeda Minoru). Mikean Clord (マイク星人クロード, Maiku Seijin Kurōdo): A vine-themed criminal from Planet Mike who is charged with several counts of mass murder and inhuman experimentation stemming from his stealing young women's nutrients to cure his sister Teresa, who is dating Hoji. Despite learning of Clord's goal and being initially torn over allowing him to continue, Hoji ultimately deletes him before he can kill another group of young women. Clord is voiced by Yuuki Tsujimoto (辻本 祐樹, Tsujimoto Yūki), who also portrays his human form. Aladonian Gyanjava (アラドン星人ギャンジャバ, Aradon Seijin Gyanjaba): A cricket-themed bank robber from Planet Aladon who is charged with burglary and child abduction, having killed Yaako's parents to take advantage of her natural ability to manipulate locks. After requesting Agent Abrella's help to access the Deka Base's systems, Yaako betrays Gyanjava and helps the Dekarangers foil his latest robbery. Gyanjava dons a Muscle Gear to evade capture and judgement before piloting a Kaijuki called Cannon Gladiator 4 (キャノングラディエーター4, Kaijūki Kyanon Guradiētā Fō) to crush the Dekarangers, only to be thwarted and judged by Deka Bike Robo.
In particular, opposition lawmakers were quick to condemn the communique to Norway about the Nobel Prize, widely questioning Trump's mental fitness for office: Andy Kim, who sits on the House Foreign Affairs Committee, described it as "unhinged and embarrassing", and Chris Murphy of the Senate Foreign Affairs Committee as "the ramblings of a man who has lost touch with reality". American historian Anne Applebaum wrote that Trump is "maniacally, unhealthily obsessive" about the Nobel Peace Prize and uses it as justification for an invasion of Greenland. Gavin Newsom criticised Europe's response to Trump's tariff threats as weak and "pathetic" while speaking on the sidelines of the World Economic Forum in and called on EU leaders to present a unified and more assertive stance toward the US. Experts said a US invasion of Greenland would violate US law and could spark a constitutional crisis. A poll from YouGov in mid-January found only 8% of Americans supported using military force to take Greenland from Denmark, with 73% opposition. "Buying" Greenland had only 28% support, with 45% opposition.
Winemakers differ in when they choose to inoculate their must with LAB, with some winemakers pitching the bacteria at the same time as the yeast, allowing both alcoholic and malolactic fermentations to run concurrently, while some wait till the end of fermentation when the wine is racked off its lees and into barrel, and others doing it somewhere between. For practitioners of minimalist or "natural winemaking" who choose not to inoculate with cultured LAB, malolactic fermentation can happen at any time depending on several factors such as the microbiological flora of the winery and the competing influences of these other microbes. All options have potential benefits and disadvantages. The benefits of inoculating for MLF during alcoholic fermentation include:
Sources: en.wikipedia.org
== See also == Discrete Fourier transform – Function in discrete mathematics − for computing periodicity in evenly spaced data Fourier transform – Mathematical transform that expresses a function of time as a function of frequency Fourier transform spectroscopy – Spectroscopy based on time- or space-domain dataPages displaying short descriptions of redirect targets Least-squares spectral analysis – Periodicity computation method − for computing periodicity in unevenly spaced data
The RTG was invented in 1954 by Mound Laboratories scientists Kenneth (Ken) C. Jordan (1921–2008) and John Birden (1918–2011). They were inducted into the National Inventors Hall of Fame in 2013. Jordan and Birden worked on an Army Signal Corps contract (R-65-8- 998 11-SC-03-91) beginning on 1 January 1957, to conduct research on radioactive materials and thermocouples suitable for the direct conversion of heat to electrical energy using polonium-210 as the heat source. RTGs were developed in the US during the late 1950s by Mound Laboratories in Miamisburg, Ohio, under contract with the United States Atomic Energy Commission. The project was led by Dr. Bertram C. Blanke. The first RTG launched into space by the United States was SNAP 3B in 1961 powered by 96 grams of plutonium-238 metal, aboard the Navy Transit 4A spacecraft. One of the first terrestrial uses of RTGs was in 1966 by the US Navy at uninhabited Fairway Rock in Alaska. RTGs were used at that site until 1995. A common RTG application is spacecraft power supply. Several generations of RTG design have been used for probes that traveled far from the Sun, rendering solar panels impractical. As such, they have been used for Pioneer 10 and 11; Voyager 1 and 2; Galileo; Ulysses; Cassini; New Horizons; and are planned for the Dragonfly mission to Titan. RTGs were also used instead of solar panels to power the two Viking landers, and for the scientific experiments left on the Moon by the crews of Apollo 12 through 17 (SNAP 27s).
Styrene can be obtained in one stage if this reaction is conducted at elevated temperatures (315–440 °C (599–824 °F)) and pressures (0.35–0.7 MPa (51–102 psi)), in presence of an aluminosilicate catalyst.
Jacky Klein (born 28 January 1977) art historian, broadcaster, author; co-presented Britain's Lost Masterpieces for BBC4; co-authored book with sister, Suzy Klein, What is Contemporary Art? A Children's Guide, commissioned by the Museum of Modern Art, New York, published by Thames & Hudson; has also authored works on Wyndham Lewis and Grayson Perry; in 2015, was Executive Editor at Tate Publishing Melanie Klein (30 March 1882 – 22 September 1960), Austrian Jewish British author and psychoanalyst known for work in child analysis; was primary figure in development of object relations theory, suggesting that pre-verbal existential anxiety in infancy catalysed formation of unconscious, resulting in unconscious splitting of the world into good and bad idealizations; how child resolves that split depends on constitution of child and the character of nurturing the child experiences, and quality of resolution can inform presence, absence, and/or type of distresses a person experiences later in life. Suzy Klein (born 1 April 1975) author and radio and television presenter; Head of Arts and Classical Music TV for the BBC; winner of William Hardcastle Award for Journalism; was assistant producer at BBC Radio 4 on programmes including Start the Week; then moved to BBC Television, working as director and producer on arts and music films.
Sources: en.wikipedia.org
This combined testing of OQ and PQ phases is sanctioned by the European Commission Enterprise Directorate-General within ‘Annex 15 to the EU Guide to Good Manufacturing Practice guide’ (2001, p. 6) which states that:
where Δσ is the change in free energy of the particle, σps is the surface potential between the particle and interface, σpl is the potential between the particle and the liquid phase and σsl is the surface potential between the solid and liquid phases. This expression is valid at low solidification velocities, when the system is shifted only slightly from equilibrium. At high solidification velocities, kinetics must also be taken into consideration. There will be a liquid film between the front and particle to maintain constant transport of the molecules which are incorporated into the growing crystal. When the front velocity increases, this film thickness (d) will decrease due to increasing drag forces. A critical velocity (vc) occurs when the film is no longer thick enough to supply the needed molecular supply. At this speed the particle will be engulfed. Most authors express vc as a function of particle size where
1990) Jack Ridley, American air force officer and test pilot, flew the Bell X-1 jet craft on its inaugural flight; as Jackie Lynwood Ridley, in Garvin, Oklahoma, United States (killed in plane crash, 1957) Died: Scotty Davidson, 24, Canadian hockey player, right wing for the Toronto Blueshirts in 1912 to 1914, helped Toronto win its first Stanley Cup (killed in France) (b. 1892)
Sources: en.wikipedia.org
It is a synthetic tetrapeptide. Its sequence was derived from research on peptide fractions of bovine pineal extract, and the intact AEDG sequence has not been demonstrated as an abundant free peptide in human tissue.
AEDG is the one-letter code for the four amino acids alanine, glutamate, aspartate and glycine in that order. The same molecule is written in three-letter form as Ala-Glu-Asp-Gly.
Identity is normally confirmed by mass spectrometry against the calculated mass of roughly 390.35 g/mol. Purity is then estimated by reversed-phase high-performance liquid chromatography with ultraviolet detection.
Reversed-phase high-performance liquid chromatography is run alongside mass spectrometry. The chromatogram separates components and gives a purity figure, while the mass spectrum confirms that the measured molecular mass matches the expected sequence. Neither measurement on its own is treated as sufficient.